MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics experienced significant insider selling recently, with executives offloading over one million dollars in stock. Fifteen transactions occurred, all involving divestments rather than acquisitions. This activity follows a period of downward price pressure, as the equity currently trades near its fifty-two-week low despite a positive earnings report last August.
Ticker: MPLT Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MapLight Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
138.38
Quantity 42,972 +29.5%
Value US$226,212
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
167.78
Quantity 86,868 -47.7%
Value US$1,388,421
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
51.69
Quantity 75,228 -33.4%
Value US$4,584,259
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
8.08
Quantity 10,167 -6.7%
Value US$82,149
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
7.84
Quantity 12,248 -6.8%
Value US$96,024
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
8.08
Quantity 15,355 -4.9%
Value US$124,068
3.8
Hanson Kristopher Officer Officer
Transaction date
Proposed sale
Price
7.81
Quantity 9,020
Value US$70,446
3.6
GILLIS JONATHAN Officer Officer
Transaction date
Proposed sale
Price
7.81
Quantity 10,167
Value US$79,404
3.8
Foff Erin Pennock Officer Officer
Transaction date
Proposed sale
Price
7.81
Quantity 15,355
Value US$119,922
3.8
Kroeger Christopher A. Officer Officer
Transaction date
Proposed sale
Price
7.81
Quantity 73,691
Value US$575,527
3.8
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
7.81
Quantity 11,513
Value US$89,917
1.4
ROBERT MALENKA Director Non-Executive Director
Transaction date
Proposed sale
Price
7.81
Quantity 14,809
Value US$115,658
3.6
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
7.81
Quantity 12,500
Value US$97,625
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
11.67
Quantity 16,509 -10.8%
Value US$192,660
3.8
Hanson Kristopher Officer Officer
Transaction date
Proposed sale
Price
12.08
Quantity 16,509
Value US$199,429
2.2
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
11.38
Quantity 4,400,000 +21.0%
Value US$50,072,000
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.54
Quantity 22,082 -9.8%
Value US$276,908
3.8
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
13.02
Quantity 22,082
Value US$287,508
3.8
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
13.02
Quantity 22,082
Value US$287,508
2.3
Novo Holdings A/S Former Affiliate
Transaction date
Proposed sale
Price
15.02
Quantity 1,600,000
Value US$24,032,000
2.2
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 1,000,000 +5.0%
Value US$13,000,000
2.2
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
12.63
Quantity 3,000 +0.0%
Value US$37,890
2.2
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
11.69
Quantity 65,137 +0.3%
Value US$761,393
2.2
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
10.74
Quantity 141,088 +0.7%
Value US$1,515,511
1.4
Cox Troy Non-Executive Director
Transaction date
Purchase
Price
9.52
Quantity 15,620 New position
Value US$148,702
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
38.39
Quantity 200 -0.1%
Value US$7,678
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
37.70
Quantity 14,140 -7.5%
Value US$533,078
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
37.05
Quantity 2,833 -1.5%
Value US$104,963
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
38.17
Quantity 900 -0.6%
Value US$34,353
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
37.61
Quantity 16,969 -10.5%
Value US$638,204
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
36.51
Quantity 600 -0.4%
Value US$21,906
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.90
Quantity 16,779 -1.3%
Value US$635,924
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.90
Quantity 2,077 -0.9%
Value US$78,718
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.90
Quantity 1,130 -0.8%
Value US$42,827
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.90
Quantity 3,656 -1.2%
Value US$138,562
3.6
ANATOL KREITZER Officer Officer
Transaction date
Proposed sale
Price
37.22
Quantity 17,173
Value US$639,179
3.6
JONATHAN GILLIS Officer Officer
Transaction date
Proposed sale
Price
37.22
Quantity 18,469
Value US$687,416
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
37.44
Quantity 1,592 -0.8%
Value US$59,604
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.66
Quantity 7,464 -3.7%
Value US$273,630
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
37.44
Quantity 1,476 -0.9%
Value US$55,261
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.66
Quantity 6,979 -4.1%
Value US$255,850
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.96
Quantity 92 -0.0%
Value US$3,492
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.26
Quantity 28,091 -2.2%
Value US$1,046,671
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.46
Quantity 40,899 -3.1%
Value US$1,491,178
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.96
Quantity 12 -0.0%
Value US$456
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.26
Quantity 3,526 -1.5%
Value US$131,379
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.45
Quantity 5,009 -2.1%
Value US$182,578
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.96
Quantity 11 -0.0%
Value US$418
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.26
Quantity 3,331 -2.2%
Value US$124,113
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.45
Quantity 4,776 -3.1%
Value US$174,085
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.96
Quantity 19 -0.0%
Value US$721
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.26
Quantity 5,865 -1.9%
Value US$218,530
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.46
Quantity 9,163 -2.9%
Value US$334,083
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.94
Quantity 4,510 -2.2%
Value US$166,599
3.6
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.13
Quantity 5,545 -2.6%
Value US$200,341
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.94
Quantity 4,699 -2.7%
Value US$173,581
3.6
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.13
Quantity 5,356 -3.0%
Value US$193,512
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.54
Quantity 90 -0.0%
Value US$3,379
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.99
Quantity 42,738 -3.1%
Value US$1,580,879
3.8
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.00
Quantity 18,950 -1.4%
Value US$682,200
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.54
Quantity 12 -0.0%
Value US$450
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.99
Quantity 5,393 -2.2%
Value US$199,487
3.8
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.00
Quantity 2,238 -0.9%
Value US$80,568
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.54
Quantity 10 -0.0%
Value US$375
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.99
Quantity 5,103 -3.2%
Value US$188,760
3.8
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.00
Quantity 2,147 -1.3%
Value US$77,292
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.54
Quantity 18 -0.0%
Value US$676
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.99
Quantity 8,972 -2.7%
Value US$331,874
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.00
Quantity 4,465 -1.3%
Value US$160,740
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Planned sale
Price
37.04
Quantity 7,845 -2.3%
Value US$290,579
3.8
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Planned sale
Price
36.16
Quantity 7,155 -2.1%
Value US$258,725
3.6
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 36,284
Value US$1,375,526
3.6
Jonathan Gillis Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 36,979
Value US$1,401,874
3.6
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 33,605
Value US$1,273,966
3.8
Foff Erin Pennock Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 48,158
Value US$1,825,670
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-16 2026-10-15 S Sale

Chief Executive Officer

Executive Director
42,972 +29.5%
138.38
US$226,212
42,972 +29.5% 138.38 US$226,212
2026-10-16 2026-10-15 S Sale

General Counsel

Officer
86,868 -47.7%
167.78
US$1,388,421
86,868 -47.7% 167.78 US$1,388,421
2026-10-16 2026-10-15 S Sale

Chief Scientific Officer

Officer
75,228 -33.4%
51.69
US$4,584,259
75,228 -33.4% 51.69 US$4,584,259
2026-10-16 2026-10-15 S Sale

CAO and Interim CFO

Officer
10,167 -6.7%
8.08
US$82,149
10,167 -6.7% 8.08 US$82,149
2026-10-16 2026-10-15 S Sale

Chief Discovery Officer

Officer
12,248 -6.8%
7.84
US$96,024
12,248 -6.8% 7.84 US$96,024
2026-10-16 2026-10-15 S Sale

Chief Medical Officer

Officer
15,355 -4.9%
8.08
US$124,068
15,355 -4.9% 8.08 US$124,068
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
9,020
7.81
US$70,446
9,020 7.81 US$70,446
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
10,167
7.81
US$79,404
10,167 7.81 US$79,404
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
15,355
7.81
US$119,922
15,355 7.81 US$119,922
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
73,691
7.81
US$575,527
73,691 7.81 US$575,527
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
11,513
7.81
US$89,917
11,513 7.81 US$89,917
2026-10-15 2026-10-15 PrS Proposed sale

Director

Non-Executive Director
14,809
7.81
US$115,658
14,809 7.81 US$115,658
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
12,500
7.81
US$97,625
12,500 7.81 US$97,625
2026-09-18 2026-09-16 PlS Planned sale

General Counsel

Officer
16,509 -10.8%
11.67
US$192,660
16,509 -10.8% 11.67 US$192,660
2026-09-16 2026-09-16 PrS Proposed sale

Officer

Officer
16,509
12.08
US$199,429
16,509 12.08 US$199,429
2026-08-18 2026-08-14 B Purchase Large shareholder
4,400,000 +21.0%
11.38
US$50,072,000
4,400,000 +21.0% 11.38 US$50,072,000
2026-08-04 2026-08-03 PlS Planned sale

Chief Scientific Officer

Officer
22,082 -9.8%
12.54
US$276,908
22,082 -9.8% 12.54 US$276,908
2026-08-03 2026-08-03 PrS Proposed sale

Officer

Officer
22,082
13.02
US$287,508
22,082 13.02 US$287,508
2026-08-03 2026-08-03 PrS Proposed sale

Officer

Officer
22,082
13.02
US$287,508
22,082 13.02 US$287,508
2026-07-30 2026-07-30 PrS Proposed sale

Former Affiliate

1,600,000
15.02
US$24,032,000
1,600,000 15.02 US$24,032,000
2026-07-30 2026-07-30 B Purchase Large shareholder
1,000,000 +5.0%
13.00
US$13,000,000
1,000,000 +5.0% 13.00 US$13,000,000
2026-07-30 2026-07-29 B Purchase Large shareholder
3,000 +0.0%
12.63
US$37,890
3,000 +0.0% 12.63 US$37,890
2026-07-30 2026-07-28 B Purchase Large shareholder
65,137 +0.3%
11.69
US$761,393
65,137 +0.3% 11.69 US$761,393
2026-07-30 2026-07-28 B Purchase Large shareholder
141,088 +0.7%
10.74
US$1,515,511
141,088 +0.7% 10.74 US$1,515,511
2026-07-28 2026-07-28 B Purchase Non-Executive Director
15,620 New position
9.52
US$148,702
15,620 New position 9.52 US$148,702
2026-07-20 2026-07-17 PlS Planned sale

Chief Discovery Officer

Officer
200 -0.1%
38.39
US$7,678
200 -0.1% 38.39 US$7,678
2026-07-20 2026-07-17 PlS Planned sale

Chief Discovery Officer

Officer
14,140 -7.5%
37.70
US$533,078
14,140 -7.5% 37.70 US$533,078
2026-07-20 2026-07-17 PlS Planned sale

Chief Discovery Officer

Officer
2,833 -1.5%
37.05
US$104,963
2,833 -1.5% 37.05 US$104,963
2026-07-20 2026-07-17 PlS Planned sale

CAO and Interim CFO

Officer
900 -0.6%
38.17
US$34,353
900 -0.6% 38.17 US$34,353
2026-07-20 2026-07-17 PlS Planned sale

CAO and Interim CFO

Officer
16,969 -10.5%
37.61
US$638,204
16,969 -10.5% 37.61 US$638,204
2026-07-20 2026-07-17 PlS Planned sale

CAO and Interim CFO

Officer
600 -0.4%
36.51
US$21,906
600 -0.4% 36.51 US$21,906
2026-07-17 2026-07-17 S Sale

Chief Executive Officer

Executive Director
16,779 -1.3%
37.90
US$635,924
16,779 -1.3% 37.90 US$635,924
2026-07-17 2026-07-17 S Sale

Chief Scientific Officer

Officer
2,077 -0.9%
37.90
US$78,718
2,077 -0.9% 37.90 US$78,718
2026-07-17 2026-07-17 S Sale

General Counsel

Officer
1,130 -0.8%
37.90
US$42,827
1,130 -0.8% 37.90 US$42,827
2026-07-17 2026-07-17 S Sale

Chief Medical Officer

Officer
3,656 -1.2%
37.90
US$138,562
3,656 -1.2% 37.90 US$138,562
2026-07-17 2026-07-17 PrS Proposed sale

Officer

Officer
17,173
37.22
US$639,179
17,173 37.22 US$639,179
2026-07-17 2026-07-17 PrS Proposed sale

Officer

Officer
18,469
37.22
US$687,416
18,469 37.22 US$687,416
2026-07-20 2026-07-16 S Sale

Chief Discovery Officer

Officer
1,592 -0.8%
37.44
US$59,604
1,592 -0.8% 37.44 US$59,604
2026-07-20 2026-07-16 S Sale

Chief Discovery Officer

Officer
7,464 -3.7%
36.66
US$273,630
7,464 -3.7% 36.66 US$273,630
2026-07-20 2026-07-16 S Sale

CAO and Interim CFO

Officer
1,476 -0.9%
37.44
US$55,261
1,476 -0.9% 37.44 US$55,261
2026-07-20 2026-07-16 S Sale

CAO and Interim CFO

Officer
6,979 -4.1%
36.66
US$255,850
6,979 -4.1% 36.66 US$255,850
2026-07-17 2026-07-16 S Sale

Chief Executive Officer

Executive Director
92 -0.0%
37.96
US$3,492
92 -0.0% 37.96 US$3,492
2026-07-17 2026-07-16 S Sale

Chief Executive Officer

Executive Director
28,091 -2.2%
37.26
US$1,046,671
28,091 -2.2% 37.26 US$1,046,671
2026-07-17 2026-07-16 S Sale

Chief Executive Officer

Executive Director
40,899 -3.1%
36.46
US$1,491,178
40,899 -3.1% 36.46 US$1,491,178
2026-07-17 2026-07-16 S Sale

Chief Scientific Officer

Officer
12 -0.0%
37.96
US$456
12 -0.0% 37.96 US$456
2026-07-17 2026-07-16 S Sale

Chief Scientific Officer

Officer
3,526 -1.5%
37.26
US$131,379
3,526 -1.5% 37.26 US$131,379
2026-07-17 2026-07-16 S Sale

Chief Scientific Officer

Officer
5,009 -2.1%
36.45
US$182,578
5,009 -2.1% 36.45 US$182,578
2026-07-17 2026-07-16 S Sale

General Counsel

Officer
11 -0.0%
37.96
US$418
11 -0.0% 37.96 US$418
2026-07-17 2026-07-16 S Sale

General Counsel

Officer
3,331 -2.2%
37.26
US$124,113
3,331 -2.2% 37.26 US$124,113
2026-07-17 2026-07-16 S Sale

General Counsel

Officer
4,776 -3.1%
36.45
US$174,085
4,776 -3.1% 36.45 US$174,085
2026-07-17 2026-07-16 S Sale

Chief Medical Officer

Officer
19 -0.0%
37.96
US$721
19 -0.0% 37.96 US$721
2026-07-17 2026-07-16 S Sale

Chief Medical Officer

Officer
5,865 -1.9%
37.26
US$218,530
5,865 -1.9% 37.26 US$218,530
2026-07-17 2026-07-16 S Sale

Chief Medical Officer

Officer
9,163 -2.9%
36.46
US$334,083
9,163 -2.9% 36.46 US$334,083
2026-07-20 2026-07-15 S Sale

Chief Discovery Officer

Officer
4,510 -2.2%
36.94
US$166,599
4,510 -2.2% 36.94 US$166,599
2026-07-20 2026-07-15 S Sale

Chief Discovery Officer

Officer
5,545 -2.6%
36.13
US$200,341
5,545 -2.6% 36.13 US$200,341
2026-07-20 2026-07-15 S Sale

CAO and Interim CFO

Officer
4,699 -2.7%
36.94
US$173,581
4,699 -2.7% 36.94 US$173,581
2026-07-20 2026-07-15 S Sale

CAO and Interim CFO

Officer
5,356 -3.0%
36.13
US$193,512
5,356 -3.0% 36.13 US$193,512
2026-07-17 2026-07-15 S Sale

Chief Executive Officer

Executive Director
90 -0.0%
37.54
US$3,379
90 -0.0% 37.54 US$3,379
2026-07-17 2026-07-15 S Sale

Chief Executive Officer

Executive Director
42,738 -3.1%
36.99
US$1,580,879
42,738 -3.1% 36.99 US$1,580,879
2026-07-17 2026-07-15 S Sale

Chief Executive Officer

Executive Director
18,950 -1.4%
36.00
US$682,200
18,950 -1.4% 36.00 US$682,200
2026-07-17 2026-07-15 S Sale

Chief Scientific Officer

Officer
12 -0.0%
37.54
US$450
12 -0.0% 37.54 US$450
2026-07-17 2026-07-15 S Sale

Chief Scientific Officer

Officer
5,393 -2.2%
36.99
US$199,487
5,393 -2.2% 36.99 US$199,487
2026-07-17 2026-07-15 S Sale

Chief Scientific Officer

Officer
2,238 -0.9%
36.00
US$80,568
2,238 -0.9% 36.00 US$80,568
2026-07-17 2026-07-15 S Sale

General Counsel

Officer
10 -0.0%
37.54
US$375
10 -0.0% 37.54 US$375
2026-07-17 2026-07-15 S Sale

General Counsel

Officer
5,103 -3.2%
36.99
US$188,760
5,103 -3.2% 36.99 US$188,760
2026-07-17 2026-07-15 S Sale

General Counsel

Officer
2,147 -1.3%
36.00
US$77,292
2,147 -1.3% 36.00 US$77,292
2026-07-17 2026-07-15 S Sale

Chief Medical Officer

Officer
18 -0.0%
37.54
US$676
18 -0.0% 37.54 US$676
2026-07-17 2026-07-15 S Sale

Chief Medical Officer

Officer
8,972 -2.7%
36.99
US$331,874
8,972 -2.7% 36.99 US$331,874
2026-07-17 2026-07-15 S Sale

Chief Medical Officer

Officer
4,465 -1.3%
36.00
US$160,740
4,465 -1.3% 36.00 US$160,740
2026-07-17 2026-07-15 PlS Planned sale

Chief Medical Officer

Officer
7,845 -2.3%
37.04
US$290,579
7,845 -2.3% 37.04 US$290,579
2026-07-17 2026-07-15 PlS Planned sale

Chief Medical Officer

Officer
7,155 -2.1%
36.16
US$258,725
7,155 -2.1% 36.16 US$258,725
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
36,284
37.91
US$1,375,526
36,284 37.91 US$1,375,526
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
36,979
37.91
US$1,401,874
36,979 37.91 US$1,401,874
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
33,605
37.91
US$1,273,966
33,605 37.91 US$1,273,966
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
48,158
37.91
US$1,825,670
48,158 37.91 US$1,825,670

See older MapLight Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock MapLight Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime